Literature DB >> 19110887

Health-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time.

Akiko Ozaki1, Yuichi Inoue, Toru Nakajima, Kenichi Hayashida, Makoto Honda, Yoko Komada, Kiyohisa Takahashi.   

Abstract

OBJECTIVE: To evaluate the health-related quality life (HRQOL) of drug-naïve patients with narcolepsy with cataplexy (NAwith CA), narcolepsy without cataplexy (NA without CA) and idiopathic hypersomnia without long sleep time (IHS without LST), and to explore the factors influencing the HRQOL. Factors associated with the occurrence of automobile accidents are also discussed.
METHODS: A total of 137 consecutive drug naïve patients who met the criteria of the 2nd edition of the International Classification of Sleep Disorders (NA with CA, n = 28; NA without CA, n = 27; IHS without LST, n = 82) were enrolled. The patients were asked to fill out questionnaires, including the SF-36, Epworth Sleepiness Scale (ESS), sociodemographic variables, and items regarding driving habits and the experiences related to automobile accidents.
RESULTS: All 3 diagnostic groups had significantly lower scores in most SF-36 domains compared with Japanese normative data. Significant differences among the 3 diagnostic groups were not observed. Specific factors in SF-36 domains were not found with multiple linear regression analyses, while disease duration was positively correlated with mental health among all subjects. Among the patients reporting driving habits, ESS score (> or =16) was positively associated with the experience of automobile accidents.
CONCLUSIONS: Our results indicated that HRQOL decreases in drug-naïve patients with hypersomnia, but neither disease category nor severity of the disorder appears as an associated factor. Increased severity of hypersomnia, however, was thought to play an important role in the occurrence of automobile accidents.

Entities:  

Mesh:

Year:  2008        PMID: 19110887      PMCID: PMC2603535     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  30 in total

1.  The contributing role of sleepiness in highway vehicle accidents.

Authors:  S Garbarino; L Nobili; M Beelke; F De Carli; F Ferrillo
Journal:  Sleep       Date:  2001-03-15       Impact factor: 5.849

2.  SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers.

Authors:  D Léger; K Scheuermaier; P Philip; M Paillard; C Guilleminault
Journal:  Psychosom Med       Date:  2001 Jan-Feb       Impact factor: 4.312

Review 3.  Epidemiology of obstructive sleep apnea: a population health perspective.

Authors:  Terry Young; Paul E Peppard; Daniel J Gottlieb
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

4.  Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine.

Authors:  A L Chesson; W M Anderson; M Littner; D Davila; K Hartse; S Johnson; M Wise; J Rafecas
Journal:  Sleep       Date:  1999-12-15       Impact factor: 5.849

5.  Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard.

Authors:  M W Johns
Journal:  J Sleep Res       Date:  2000-03       Impact factor: 3.981

6.  The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study.

Authors:  C M Baldwin; K A Griffith; F J Nieto; G T O'Connor; J A Walsleben; S Redline
Journal:  Sleep       Date:  2001-02-01       Impact factor: 5.849

7.  Health-related quality of life in narcolepsy.

Authors:  E Daniels; M A King; I E Smith; J M Shneerson
Journal:  J Sleep Res       Date:  2001-03       Impact factor: 3.981

8.  Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome.

Authors:  Tsuneto Akashiba; Seiji Kawahara; Toshiki Akahoshi; Chiharu Omori; Osamu Saito; Tohru Majima; Takashi Horie
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

9.  Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory.

Authors:  Misa Takegami; Yoshimi Suzukamo; Takafumi Wakita; Hiroyuki Noguchi; Kazuo Chin; Hiroshi Kadotani; Yuichi Inoue; Yasunori Oka; Takaya Nakamura; Joseph Green; Murray W Johns; Shunichi Fukuhara
Journal:  Sleep Med       Date:  2008-09-27       Impact factor: 3.492

10.  Driver sleepiness and risk of car crashes in Shenyang, a Chinese northeastern city: population-based case-control study.

Authors:  Gai-Fen Liu; Song Han; Duo-Hong Liang; Feng-Zhi Wang; Xin-Zhu Shi; Jian Yu; Zheng-Lai Wu
Journal:  Biomed Environ Sci       Date:  2003-09       Impact factor: 3.118

View more
  18 in total

1.  Giving a voice to cataplectic experience: recollections from patients with narcolepsy type 1.

Authors:  Christian Franceschini; Chiara Fante; Maria Claudia Folli; Maria Filosa; Fabio Pizza; Elena Antelmi; Francesca Ingravallo; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

Review 2.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

3.  Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.

Authors:  Sandor Kantor; Takatoshi Mochizuki; Stefan N Lops; Brian Ko; Elizabeth Clain; Erika Clark; Mihoko Yamamoto; Thomas E Scammell
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

4.  Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Donald L Bliwise; Amanda A Freeman; Andrew Jenkins; David B Rye
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

5.  Increased mortality in narcolepsy.

Authors:  Maurice M Ohayon; Jed Black; Chinglin Lai; Mark Eller; Diane Guinta; Arun Bhattacharyya
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

6.  Factors associated with duration before receiving definitive diagnosis of narcolepsy among Japanese patients affected with the disorder.

Authors:  Yoichiro Ueki; Kenichi Hayashida; Yoko Komada; Masaki Nakamura; Mina Kobayashi; Makio Iimori; Yuichi Inoue
Journal:  Int J Behav Med       Date:  2014-12

7.  Body mass index-independent metabolic alterations in narcolepsy with cataplexy.

Authors:  Francesca Poli; Giuseppe Plazzi; Guido Di Dalmazi; Danilo Ribichini; Valentina Vicennati; Fabio Pizza; Emmanuel Mignot; Pasquale Montagna; Renato Pasquali; Uberto Pagotto
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

8.  Health, social and economic consequences of hypersomnia: a controlled national study from a national registry evaluating the societal effect on patients and their partners.

Authors:  Poul Jennum; Rikke Ibsen; Kirsten Avlund; Jakob Kjellberg
Journal:  Eur J Health Econ       Date:  2013-06-12

9.  Developing a cognitive behavioral therapy for hypersomnia using telehealth: a feasibility study.

Authors:  Jason C Ong; Spencer C Dawson; Jennifer M Mundt; Cameron Moore
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

10.  Armodafinil in the treatment of excessive sleepiness.

Authors:  Russell Rosenberg; Richard Bogan
Journal:  Nat Sci Sleep       Date:  2010-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.